Roux-en-Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity.
Nadeeja Niranjalie WijayatungaValerie G SamsJohn A DawsonMatthew L ManciniGregory J ManciniNaima Moustaid-MoussaPublished in: Diabetes/metabolism research and reviews (2018)
Changes in serum metabolites and FA at 6 months post-RYGB surgery in this pilot study with limited number of participants are suggestive of metabolic improvement; larger studies are warranted for confirmation.
Keyphrases
- roux en y gastric bypass
- weight loss
- minimally invasive
- bariatric surgery
- obese patients
- gastric bypass
- coronary artery bypass
- ms ms
- fatty acid
- type diabetes
- metabolic syndrome
- insulin resistance
- weight gain
- physical activity
- percutaneous coronary intervention
- acute coronary syndrome
- case control
- high fat diet induced
- skeletal muscle
- adipose tissue
- atrial fibrillation